Strong YoY growth masks Q1 flatness; new programs ramping cautiously
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met 500 Cr FY26 target; on track for 565±5% FY27 guidance. New programs progressing as outlined, but no upside surprise evident.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong YoY revenue (31.5%) masks sequential stall (+0.5%) and PAT weakness (7.7% vs revenue growth). New catalysts (BMW, Royal Enfield, KTM recovery) are real but ramping cautiously; management deliberately held guidance despite tailwinds, signaling measured confidence. Multi-supplier risk on Royal Enfield and execution risk on adjacent verticals (aerospace, robotics) are material.
₹132.3 Cr
Revenue · +31.5% YoY₹8.9 Cr
Reported PAT · +7.7% YoYFlat
Margins · vs guidance: CorroboratedDid the claims hold up?
KTM has bounced back to pre-COVID levels
METManagement claims recovery but no revenue breakout shown; KTM contribution not quantified in this quarter
Royal Enfield is a very big domestic order
OVERSTATED10,000 sets/month nominated, currently sustaining 7.5-8,000 units/month; 8 months into ramp, still sub-scale
BMW Project Venus SOP on track for October 2026
METLevel 1 approval done, final approval scheduled Oct 24, pilot supplies already started
Coming times showing very encouraging outlook
MISSQoQ revenue +0.5%, PAT -27.9% QoQ; management did NOT upgrade FY27 guidance despite new catalysts
Maintaining EBITDA margin of ~24%
METQ1 OPM reported at 24.1%; consistent with prior year 24.1%
Earnings quality
What changed since the last call
KTM revenue stabilizing vs prior concern
UpgradePrior call: KTM in recovery mode post-insolvency. Q1 call: 'Bounced back, pre-COVID levels or slightly above, new Duke 790 launching, good forecast.' Narrative upgraded but no hard numbers shared.
Royal Enfield empanelment announced, scaling production
NewJanuary 2026 commercial supplies began; 10,000 sets/month nominated (350 CC motorcycle). Currently sustaining 7.5-8,000. Multi-supplier, confidential scale withheld by management.
BMW Project Venus accelerating approvals
UpgradePrior: Project underway, approvals pending. Q1: Level 1 approval granted, final approval Oct 24, pilot supplies started. Incremental de-risking.
FY27 guidance NOT revised upward
NeutralDespite KTM recovery, Royal Enfield win, BMW acceleration, management explicitly held 565±5% guidance. Rationale: customers not growing >20%, RACL share <20% per customer, mid-year guidance changes inappropriate.
Capex disclosed; heat treatment replacement underway
Neutral₹77.4 Cr capex: ₹40 Cr heat treatment plant replacement (foundation Jan, commissioning Jan 27), ₹35 Cr capacity expansion. Strategic but capital-intensive; no acceleration vs plan.
The Q&A
Moderate. Analysts pressed on guidance revision (Shashank Kanodia, Abhisar Jain), Royal Enfield scale and market share (Jainam Madrecha), ZF trajectory (Prabh answered directly). Management stood firm: not upgrading mid-year, withheld Royal Enfield volume % citing competitive risk, and emphasized incubation strategy for new verticals. Tone was measured, not defensive; management held their line on cautious execution.
KTM recovery trajectory — Sid
AnsweredKTM Austria bounced back to pre-COVID; RACL's Austrian subsidiary serves KTM. Bajaj India multi-sourcing strategy ongoing; RACL already supplies Royal Enfield, TVS. New opportunities with Bajaj over time.
BMW SOP status — Piyush Jain
AnsweredLevel 1 approval done, conditional shipments started, final approval Oct 24. Pilot supplies moving to customer cars now. Everything on track, no delays.
Royal Enfield details — Piyush Jain
Partial350 CC model, 10,000 sets/month nominated, currently 7.5-8,000 sustaining. Other new models under confidentiality. Competitive sensitivity; won't disclose %. Sizable business.
ZF business trajectory — Piyush Jain
AnsweredPrior sluggishness due to OEM car models. X5 platform now active, 50-60% utilization. Peak revenue shifted 2028→2030. Electric power steering project ramping end-2027/mid-2028 for American OEM; another big opportunity.
Non-auto diversification — Abhisar Jain
AnsweredAerospace/civil aviation (Airbus focus), actuators/micromotors, robotics (high demand but early stage, few Indian players). Incubation strategy: test, then scale. Will update investors in 1-2 years.
Guidance revision possibility — Shashank Kanodia
DodgedGuidance given once yearly. Even if customer grows 50-60%, RACL's share <20% per customer. Wouldn't revise mid-year. Will perform within 565±5% benchmark; possible upside but no formal change.
EBITDA margin sustainability — Shashank Kanodia
PartialShould be happy accepting these margins, maintained long-term. Nothing stationary; 2% variance quarter-to-quarter normal. Aspiration is to maintain baseline profitability.
Tax rate outlook — Shashank Kanodia
AnsweredBlended FY27 tax rate: 25.62%. Q1 elevated due to surcharge rate change in deferred tax calculation. This was explained in profitability slide.
Royal Enfield outsourcing pattern — Nisarg Shah
AnsweredYes. OEMs want to focus on assembly (commanding position). Supply chain maturity in India now allows this. RACL single-source for export; domestic OEMs multi-source. Creating niche in premium segment.
Precision manufacturing barriers — Nisarg Shah
AnsweredNot making; it's consistency at scale. Process capability, traceability, people/technology to produce 100K+ parts/month reliably. Customers won't take risk; RACL A-rated supplier = support.
Royal Enfield capacity planning — Jainam Madrecha
AnsweredMulti-supplier customer; we invest cautiously. First prove demand sustainable long-term, then add capacity. No idle capacity; won't jump on demand spikes. Deliberate ramp-up.
Product lifecycle turnover — Jainam Madrecha
AnsweredNo major end-of-life products today. One project ending but successor model (higher value-add) replacing it. Every 2-3 years add new customer, existing customers add new models.
BMW sole-source confirmation — Jainam Madrecha
AnsweredYes. Export business model: sole source per component until EOL. Global OEM strategy (supply chain risk in field). Domestic (multi-supplier) is different.
ZF competitive leverage — Bhargav Buddhadev
AnsweredLarge ZF portal RFQ system (no human intervention). Buyers globally upload requirements; RACL marketing monitors, bids if suitable. Automatic discovery; no lobbying needed.
Risk mitigation on project failures — Bhargav Buddhadev
AnsweredYes, indirectly. Customers support suppliers through cost increases, alternative business, or cash if model fails. Depends on relationship strength (A-rated vs C-rated). RACL is A-rated.
RFQ surge from Europe — Bhargav Buddhadev
AnsweredTrue, witnessing RFQ spike. Many are RFIs (requests for information) not firm RFQs. Geopolitical rebalancing real; supply chains being rewritten. Cautious optimism. Will pursue opportunity.
Capex for next 3 years — Adi
PartialThis year ₹77.4 Cr disclosed. Next year's capex will come in January. Beyond 2028-29, too early. Gear business capital-intensive; regular capex needed for growth.
5-year growth ambition & M&A — Adi
Answered15-20% annual growth, target to double revenue in 3-4 years. Non-auto opportunities (aerospace, actuators, robotics, defense) identified. Incubation model; no aggressive M&A planned yet.
Guidance
FY27 revenue ~570 Cr (±5%, = 541.5-598.5 Cr)
HighGuidance reaffirmed, not revised upward. Management explained: customers not growing >20%, RACL <20% per customer, mid-year revisions not appropriate. Q1 run-rate suggests 529 Cr annualized (below mid-point); FY27 will need Q2-Q4 acceleration.
EBITDA margin ~24.1%, maintained
HighQ1 delivered 24.1%; management aspires to maintain. Acknowledged 2% variance normal quarter-to-quarter. No margin expansion target.
FY27 capex ₹77.4 Cr (₹40 Cr heat treatment replacement + ₹35 Cr capacity)
HighFoundation laid Jan 26, building completion Oct 26, equipment arrival Sept-Oct, commissioning Oct-Dec, trial production Jan 27. Replacement is non-discretionary; expansion tied to customer ramps.
Risks the call surfaced
Customer concentration
Medium29 active customers is diversified, but loss of major customer (BMW, Royal Enfield, KTM, ZF) would be material. Royal Enfield multi-supplier adds risk.
Royal Enfield execution
Medium10,000 units/month nominated; currently 7.5-8,000. Multi-supplier model means RACL could lose share if costs rise or alternative suppliers qualify. Domestic market highly price-sensitive per management.
Sequential revenue weakness
MediumQoQ revenue +0.5% despite 31.5% YoY growth signals Q1 weakness or customer order lumps. PAT -27.9% QoQ is sharp; tax impact (surcharge rate change) cited but underlying margin may be under pressure.
Capex execution and debt
Medium₹77.4 Cr capex in FY27 (14% of annual revenue) is significant. Heat treatment plant on schedule but equipment delivery Sept-Oct critical path; delays post-commissioning (Jan 27) would impact expansion timeline and ROI.
Long-term adjacency execution
LowManagement mentioned aerospace (Airbus), robotics, actuators, industrial components as 2-3 year opportunities, but no revenue materialization and execution unknown. Distracts capex and management attention without current business impact.
Management
Score 7/10. Clear and structured. Transparent on challenges (energy crisis, geopolitical risks), catalysts (BMW, Royal Enfield, KTM recovery), and constraints (no mid-year guidance revision). Withheld some competitive details (Royal Enfield volume %, pricing) citing risk; reasonable but limits transparency. Strong track record. Met 500 Cr FY26 target, on track for 565±5% FY27. Heat treatment plant capex execution on timeline (foundation Jan, commissioning Jan 27 on track). New customer wins (BMW, Royal Enfield) progressing but still ramping; not yet transformative.
1 · Oct 24, 2026
BMW Project Venus final approval sign-off; pilot supplies ongoing
2 · Dec 2026
Heat treatment plant commissioning (foundation laid Jan 26); switch from LPG to electric
3 · Jan 2027
Heat treatment plant trial production; capex cycle easing post-commissioning
Multi-supplier risk on Royal Enfield and execution risk on adjacent verticals (aerospace, robotics) are material.
Informational and educational content only. Not investment advice.